Re-evaluating cytokine storm syndromes: dysregulated host defense or contextual immune adaptation?

Area of Science:

• Immunology
• Evolutionary Biology
• Systems Biology

Background:

• Cytokine storm syndromes are poorly defined and often mechanistically imprecise.
• High systemic cytokine levels are frequently viewed as immune dysfunction, leading to broad cytokine inhibition therapies.
• Emerging data challenge the notion that hypercytokinemia is always pathological.

Purpose of the Study:

• To redefine cytokine storm syndromes using an evolutionary, systems-immunology model.
• To reframe cytokine storm syndromes as context-specific host defense programs rather than uniform maladaptations.
• To differentiate adaptive cytokine amplification from pathological immunopathology.

Main Methods:

• Review of disease-specific cytokine storm phenotypes in viral infections, bacterial sepsis, autoimmune diseases, and immune-based therapies.
• Analysis of cytokine composition, kinetics, cellular sources, and tissue localization.
• Integration of evolutionary biology and systems immunology insights.

Main Results:

• Cytokine storm syndromes represent a spectrum of context-specific immune programs, not a single pathological entity.
• Variability exists in cytokine profiles, kinetics, cellular origins, and tissue distribution across different conditions.
• Temporal dynamics, host factors, and counter-regulatory mechanisms distinguish adaptive amplification from pathology.

Conclusions:

• Cytokine storm syndromes should be understood as context-specific immune programs with potential adaptive roles.
• Precision therapeutic strategies must consider immune context, disease stage, and signaling thresholds, moving beyond general cytokine blockade.
• Distinguishing adaptive cytokine amplification from maladaptive immunopathology is crucial for effective clinical management.